NCT06553924View on ClinicalTrials.gov

Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg and 'PrOpsynvi®' Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 14, 2024

Primary Completion Date

May 31, 2024

Study Completion Date

August 8, 2024

Conditions
PAH
Interventions
DRUG

Macitentan and Tadalafil film-coated tablets

1 tablet of Macitentan and Tadalafil film-coated tablets 10 mg/40 mg

DRUG

PrOpsynvi® macitentan and tadalafil film-coated tablets

1 tablet of Macitentan and Tadalafil film-coated tablets 10 mg/40 mg

Trial Locations (1)

382210

Cliantha Research Limited, Ahmedabad

All Listed Sponsors
lead

Humanis Saglık Anonim Sirketi

INDUSTRY

NCT06553924 - Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg and 'PrOpsynvi®' Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg | Biotech Hunter | Biotech Hunter